Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KRT81 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | AL109923.1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | CDCA8 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | FZD6 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
mRNA | ITGB4 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
mRNA | CTB-102L5.4 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |
mRNA | PERP | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
mRNA | TRIM29 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | HECTD3 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | OPN3 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |